Neuropharmacology is the branch of neuroscience which in itself is a branch of biology. Within the discipline of neuropharmacology are two branches, behavioral and molecular.
Neuropharmacology is concerned with the study of the neurochemical interactions of Neuropeptides, Neurohormones, neuromodulators, enzymes, Secondary Messenger Systems of the nervous system, co-transporters, ion channels, receptor proteins and more.
Molecular neuropharmacology also involves the study of neurological diseases (i.e. (Alzheimer's Disease) Parkinson's, Huntington's diesease, ALS, ADHA, Eating Disorders, epilepsy, multiple sclerosis, Lupus, Guillian Barre Syndrome and others) and drug abuse at regionalized portion of the brain or at the cellular level. Research in molecular neuropharmacology may overlap with the science of (biophysics) when analyzing the movement of macromolecules.
Behavioral Neuropharmacology is composed of the (psychopharmacology) and which along with neuropsychiatry divisions. Behavioral neuropharmacology will look at the net effect of psychoactive substance on the organismal scale by a means of behavioral changes.
See also
The content of this page is retrieved from http://en.wikipedia.org/wiki/Neuropharmacology under GFDL
